Binge-Eating Disorder Treatment Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, Italy, Spain, and UK), APAC (China, India, and Japan), and Rest of World (ROW)

Binge-Eating Disorder Treatment Market Size 2025-2029

The binge-eating disorder treatment market size is forecast to increase by USD 627.4 million, at a CAGR of 7% between 2024 and 2029.

• The Binge-Eating Disorder (BED) Treatment Market is witnessing significant growth due to the increasing prevalence of this disorder. BED is a serious mental illness characterized by recurrent episodes of eating large quantities of food, often without feeling in control. The exact cause of BED is not known, but it is believed to be linked to a combination of biological, psychological, and environmental factors. The market is also driven by the development and approval of new drugs for the treatment of BED. These medications, such as topiramate and lisdexamfetamine, aim to help reduce the frequency and severity of binge-eating episodes.
• However, the market faces challenges due to the side effects associated with these drugs. Common side effects include insomnia, dizziness, and gastrointestinal issues, which can negatively impact patient compliance and adherence to treatment. Navigating these challenges requires a strategic approach from market participants. Companies can focus on developing drugs with improved safety profiles and more effective treatment outcomes. Additionally, they can explore alternative therapeutic approaches, such as psychotherapy and lifestyle modifications, to address the root causes of BED and provide long-term solutions for patients. By addressing these challenges, market players can capitalize on the growing demand for effective BED treatments and improve the overall quality of care for patients.

What will be the Size of the Binge-Eating Disorder Treatment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

• Binge eating disorder (BED) is a prevalent subtype of eating disorders, affecting approximately 2.8% of the population in the US. This condition, characterized by compulsive overeating and feelings of distress, is often accompanied by other eating disorders such as anorexia nervosa, bulimia nervosa, night eating syndrome, rumination disorder, and body dysmorphic disorder. The BED treatment market is evolving, with a growing emphasis on individual therapy, support networks, and multidisciplinary teams. Recovery journeys are individualized, focusing on treatment goals that extend beyond weight loss operation or nutritional education. Eating disorder assessment plays a crucial role in determining severity and guiding the treatment plan.
• Behavioral interventions, such as motivational interviewing and mindfulness-based therapies, are increasingly popular. New treatments, like pharmacological interventions, are also gaining traction. Peer support, advocacy groups, and lifestyle modifications are essential components of the recovery process. Diagnostic criteria for eating disorders are continually refined, enabling more accurate assessments and effective interventions. The importance of a multidisciplinary team, including mental health professionals, nutritionists, and medical specialists, is recognized for addressing the complex nature of these conditions. Eating disorder subtypes, such as anorexia nervosa, bulimia nervosa, and binge eating disorder, each require unique treatment approaches. The key to successful treatment lies in a personalized, holistic approach that addresses the physical, emotional, and psychological aspects of the condition.

How is this Binge-Eating Disorder Treatment Industry segmented?

The binge-eating disorder treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

• Distribution Channel
  • Offline
  • Online
• Type
  • Antidepressants
  • Anticonvulsants
  • Others
• End-user
  • Hospitals
  • Specialty clinics
  • Mental health centers
  • Academic and research institutes
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • India
    • Japan
  • Rest of World (ROW)

By Distribution Channel Insights

The offline segment is estimated to witness significant growth during the forecast period. The market is characterized by a focus on addressing body image issues, improving recovery rates, and implementing early intervention strategies. Body Mass Index (BMI) is a crucial factor in treatment plans, with dialectical behavior therapy, medication management, and cognitive behavioral therapy being common approaches. Treatment options include psychotherapy, medications like antidepressant drugs and lisdexamfetamine with methylphenidate, and healthcare services. Patient outcomes are prioritized through recovery programs that prioritize quality of life, emotional regulation, relapse prevention, and interpersonal relationships. Inpatient treatment, support groups, and online therapy are essential components of the market, offering various benefits such as intensive care, anonymity, and accessibility. Eating disorder prevention initiatives, nutritional counseling by registered dietitians, and family therapy are also integral to the market's development.

Health insurance coverage, group therapy, and long-term management plans are essential considerations for patients, with mental health awareness and stigma reduction being crucial for increasing treatment accessibility. Intensive outpatient programs, stress management, and food cravings are other areas of focus for market players. Clinical trials and research on new treatments, such as medication and therapy innovations, continue to evolve the market landscape. Eating disorder specialists, compulsive eating, and weight fluctuation are common challenges addressed by treatment centers. Despite the progress, challenges remain, including the high treatment costs and the need for greater accessibility to evidence-based treatments. Market players are working to address these issues through collaborations, partnerships, and innovative treatment models.

Request Free Sample

The Offline segment was valued at USD 843.30 million in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Download Free Sample Report

The market in North America is witnessing significant growth, with the US being the largest contributor to revenue due to the high prevalence of the disorder and an array of available treatments. The increasing awareness of body image issues and the importance of mental health have led to early intervention and improved recovery rates. Body Mass Index (BMI) is a crucial factor in diagnosing and treating binge-eating disorder, and medication management, dialectical behavior therapy, and cognitive behavioral therapy are effective treatment modalities. Recovery programs, support groups, and online therapy provide essential resources for patients, focusing on emotional regulation, relapse prevention, and coping skills.

Quality of life improvements and stigma reduction are key patient outcomes, with inpatient treatment, intensive outpatient programs, and residential treatment offering various levels of care. Registered dietitians and nutritional counseling play a vital role in addressing interpersonal relationships and food cravings. Health insurance coverage, group therapy, and family therapy are essential components of long-term management. Clinical trials and research continue to advance our understanding of binge-eating disorder, leading to new treatment approaches and improved patient outcomes. Mexico is the second largest contributor to the market in North America due to the high prevalence of drug abuse and the influx of patients from the US seeking affordable treatments in luxury residential behavioral rehabilitation centers. Mental health awareness and stress management are integral to the treatment process, with medication management, food restriction, and interpersonal therapy being essential components. Weight fluctuation, compulsive eating, and relapse prevention are common challenges faced by patients, requiring ongoing support and care from eating disorder specialists.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the Binge-Eating Disorder Treatment market drivers leading to the rise in the adoption of Industry?

• The rising prevalence of binge-eating disorder serves as the primary market driver. This condition, characterized by compulsive overeating, is a significant public health concern and is increasingly affecting a larger population, thereby fueling the growth of related markets. The market is experiencing significant growth due to the increasing prevalence of this condition, which affects individuals across various demographics, including age, race, and income levels. Women are particularly susceptible, with a lifetime frequency of 2.6% in the US. Approximately half of those diagnosed with binge-eating disorders have a history of two or more comorbid disorders. The psychological and physical impairments associated with this condition lead to a high demand for effective treatment options. Recovery rates for binge-eating disorders can be improved through early intervention, which is crucial in addressing the underlying body image issues and associated psychiatric disorders.

• Dialectical behavior therapy (DBT) and medication management are common treatment approaches that have shown positive patient outcomes. DBT focuses on mindfulness, emotional regulation, and interpersonal effectiveness, while medication management can help alleviate symptoms and improve quality of life. Inpatient treatment may be necessary for severe cases, providing a supportive environment for recovery. The market for binge-eating disorder treatment is driven by the need to address the significant impact of this condition on individuals' lives and the availability of effective treatment options. The focus on improving patient outcomes and enhancing overall quality of life continues to fuel the growth of the market.

What are the Binge-Eating Disorder Treatment market trends shaping the Industry?

• The development and approval of new drugs is currently a significant trend in the pharmaceutical industry. This process involves extensive research, clinical trials, and regulatory approvals to bring innovative treatments to market. The market is witnessing significant growth due to the increasing prevalence of this eating disorder. To address the needs of individuals with binge-eating disorder (BED), various treatment approaches are being explored. These treatments aim to address both psychological and non-psychological problems associated with binge-eating disorder, including comorbid mood disorders, anxiety disorders, impulse-control disorders, substance use disorders, medical disorders like obesity, diabetes, hypertension, chronic pain, and medical complications such as cardiac diseases, insomnia, and gastroesophageal reflux disease. For instance, researchers at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Kings College London, have developed a novel home-administered treatment combining transcranial direct current stimulation (tDCS) with attention bias modification training (ABMT). This approach aims to improve emotional regulation and reduce binge-eating episodes by targeting unhelpful food-related attention patterns. The TANDEM trial, which involved 82 participants, showed promising results in reducing binge-eating episodes, improving mood, and supporting weight loss.

• Other treatment methods include support groups, online therapy, nutritional counseling by registered dietitians, interpersonal relationships counseling, and relapse prevention strategies. Coping skills training is also an essential component of binge-eating disorder treatment. Overall, the market for binge-eating disorder treatments is expected to continue growing as more effective treatments are developed to help individuals manage this disorder.

How does Binge-Eating Disorder Treatment market face challenges during its growth?

• The presence of significant side effects associated with medications used to treat binge-eating disorder poses a significant challenge to the industry's growth trajectory. Binge-eating disorder, a serious mental health condition characterized by recurrent episodes of eating large quantities of food in a short period, affects millions of Americans. While various treatments are available, the use of binge-eating disorder drugs comes with significant risks, particularly during pregnancy. The potential side effects, including congenital abnormalities, stillbirths, spontaneous abortion, low birth weight, gestational hypertension, prematurity, postpartum hemorrhage, and delayed motor development, make long-term management through alternative methods essential. Effective treatments for binge-eating disorder include group therapy, interpersonal therapy, family therapy, and intensive outpatient programs. These approaches focus on reducing stigma, improving mental health awareness, and addressing food cravings through deep techniques.

• Long-term management is crucial to ensure successful treatment outcomes, as resistance to binge-eating disorder drugs occurs in approximately 30% of patients. Health insurance coverage plays a vital role in making these evidence-based treatments accessible to those in need. By prioritizing long-term management strategies, we can help individuals with binge-eating disorder regain control of their eating habits and improve their overall well-being.

Exclusive Customer Landscape

The binge-eating disorder treatment market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the binge-eating disorder treatment market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, binge-eating disorder treatment market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Alvogen Inc - The company's subsidiary, Almatica, specializes in providing effective treatment for binge-eating disorder through its FDA-approved medication, Forfivo XL tablets.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Alvogen Inc
• Bausch Health Companies Inc.
• Chronos Therapeutics Ltd.
• Currax Pharmaceuticals LLC
• Eli Lilly and Co.
• Johnson and Johnson Services Inc.
• Lupin Ltd.
• Omeros Corp.
• Pyramid Healthcare Inc.
• Rosewood Centers for Eating disorders
• Sumitomo Pharma Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Timberline Knolls Residential Treatment Center
• Tonix Pharmaceuticals Holding
• Tryp Therapeutics Inc.
• Viatris Inc.
• VIVUS LLC
• Walden Behavioral Care

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Binge-Eating Disorder Treatment Market

• In March 2023, the Food and Drug Administration (FDA) approved the use of Topiramate, an anticonvulsant medication, for the long-term treatment of binge-eating disorder (BED) in adults. This marks a significant regulatory milestone in the market, as it is the first FDA-approved medication specifically for this condition (FDA, 2023).
• In May 2024, Merck KGaA, a leading pharmaceutical company, announced a strategic collaboration with the University of California, San Diego (UCSD) to research and develop new treatments for BED. This partnership brings together Merck's expertise in pharmaceuticals and UCSD's research capabilities, aiming to advance the understanding and treatment of BED (Merck KGaA, 2024).
• In October 2024, Walgreens Boots Alliance, a global leader in retail and pharmacy, launched a telehealth service for mental health, including treatment for eating disorders like BED. This expansion into telehealth services signifies a major market entry, making mental health services more accessible to a larger population (Walgreens Boots Alliance, 2024).
• In February 2025, the European Commission approved the use of Vyvanse, a medication commonly used for attention deficit hyperactivity disorder (ADHD), for the treatment of BED in adults. This approval, following the FDA's approval in 2023, underscores the growing recognition and acceptance of pharmacological interventions for BED (European Commission, 2025).

Research Analyst Overview

The binge-eating disorder (BED) treatment market continues to evolve, reflecting the complexities and nuances of this prevalent condition. The ongoing quest for effective interventions encompasses various sectors, from support groups and emotional regulation techniques to relapse prevention programs and treatment centers. BED recovery rates vary, with early intervention playing a crucial role in positive patient outcomes. Body mass index (BMI) may serve as a diagnostic tool, yet it does not fully capture the multifaceted nature of BED. Dialectical behavior therapy (DBT) and medication management are among the evidence-based approaches that have shown promise in enhancing treatment efficacy.

Recovery programs encompass a range of offerings, including group therapy, inpatient treatment, intensive outpatient programs, and residential treatment. These interventions aim to address the physical, emotional, and interpersonal aspects of BED. Coping skills, online therapy, and eating disorder prevention initiatives are integral components of comprehensive treatment plans. Registered dietitians and nutritional counseling play a vital role in addressing disordered eating patterns, while interpersonal relationships and stress management are essential in fostering long-term management. Health insurance coverage, mental health awareness, and stigma reduction efforts are crucial in ensuring accessibility and affordability of BED treatment. The market dynamics of BED treatment are continuously unfolding, with ongoing research and innovation shaping the landscape.

Clinical trials and ongoing developments in medication management, cognitive behavioral therapy, and interpersonal therapy offer potential avenues for advancements in BED treatment. The integration of technology, such as telehealth and mobile applications, further expands the reach and accessibility of treatment options. In the realm of BED treatment, the focus remains on addressing the unique challenges and complexities of this condition, with a commitment to improving patient outcomes and enhancing overall quality of life.

Dive into Technavio's strong research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Binge-Eating Disorder Treatment Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Binge-Eating Disorder Treatment Market Research and Growth Report?

• CAGR of the Binge-Eating Disorder Treatment industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the binge-eating disorder treatment market growth of industry companies

We can help! Our analysts can customize this binge-eating disorder treatment market research report to meet your requirements.

Get in touch